FDA Races in Wrong Direction
- 25 July 2003
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 301 (5632) , 466
- https://doi.org/10.1126/science.1087004
Abstract
Despite recent genetic evidence and the promise of individualized medicine, there is a continuing interest in using self-identified categories of race and ethnicity as variables in scientific and medical research. The U.S. Food and Drug Administration recently proposed a standardized approach for the collection of race and ethnicity data in clinical trials. We believe that this move fails to acknowledge new scientific data and recommend that relevant data from individuals be collected and used rather than broad group statistics. We also encourage that increased funding be committed to this important issue.Keywords
This publication has 19 references indexed in Scilit:
- The Importance of Race and Ethnic Background in Biomedical Research and Clinical PracticeNew England Journal of Medicine, 2003
- Race and GenomicsNew England Journal of Medicine, 2003
- Human Population Genetic Structure and Inference of Group MembershipAmerican Journal of Human Genetics, 2003
- Genetic Structure of Human PopulationsScience, 2002
- HUMAN MIGRATIONS AND POPULATION STRUCTURE: What We Know and Why it MattersAnnual Review of Genomics and Human Genetics, 2002
- Personalized medicine: revolutionizing drug discovery and patient careTrends in Biotechnology, 2001
- PharmacogeneticsHuman Molecular Genetics, 2001
- Molecular Basis of Ethnic Differences in Drug Disposition and ResponseAnnual Review of Pharmacology and Toxicology, 2001
- The Phylogeography of Brazilian Y-Chromosome LineagesAmerican Journal of Human Genetics, 2001
- Identifying AncestryEpidemiology, 1996